HHHuda M. Hammad

Huda M. Hammad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Huda M. Hammad has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Rima A. Safadi

    Department of Oral Medicine and Oral Surgery, Faculty of Dentistry, Jordan University of Science and Technology, P. O. Box 3030, Irbid 22110, Jordan

    2 shared publications
  • Abd-Albaset M. Odat

    Consultant Oral and Maxillofacial Surgeon, Princess Basma Teaching Hospital, Jordan Ministry of Health, Irbid, Jordan

    1 shared publication
  • Abeer M. Mikdadi

    Consultant Oral Medicine Specialist, Princess Basma Teaching Hospital, Jordan Ministry of Health, Irbid, Jordan

    1 shared publication
  • Adel M Al-Wahadneh

    Department of Pediatrics, King Hussein Medical Centre, Amman, Jordan

    1 shared publication
  • Ahmad Gharaibeh

    Teaching Department of Orthopaedics Musculoskeletal Trauma, Faculty of Medicine, University Hospital of Louise Pasteur, Pavel Jozef Safarik University, 040 11 Košice, Slovakia

    1 shared publication
  • Ahmed Al Wadiya

    Royal Derby Hospital Derby United Kingdom

    1 shared publication

Latest Publications

  • Open Access

    Maspin, Syndecan-1, and Ki-67 in the Odontogenic Keratocyst: An Immunohistochemical Analysis

    by Huda M. Hammad, Omar M. Nagrash, Rima A. Safadi

    The odontogenic keratocyst (OKC) is a controversial lesion that was reclassified as a tumor with the name “keratocystic odontogenic tumor” in 2005. The reclassification was revoked recently in 2017, with a conclusion on the need for further studies on the subject. In this study, the expressions of an important regulatory protein (maspin), an important integral membrane proteoglycan (syndecan-1), and a universal proliferation marker (Ki-67) in the epithelium of the OKC were investigated in comparison with the dentigerous cyst (DC) and ameloblastoma (AB). Twenty-six OKCs, eleven DCs, and ten conventional ABs were immunohistochemically stained for maspin, syndecan-1, and Ki-67. ImageJ was used to analyze the positivity of maspin and syndecan-1. The Ki-67 score was calculated as the percentage of positive nuclei in 5 high power fields. Analysis of variance (ANOVA) test and Studentt-test were used as appropriate. Lower expressions of maspin were noted in OKC and DC compared to those in AB, and lower expressions of syndecan-1 were noted in OKC and AB compared to those in DC. The differences, however, did not reach statistical significance (ANOVA andt-test:P>0.05). The Ki-67 score was significantly higher in OKC than in DC (t-test:P<0.05), and not significantly different from AB (t-test:P>0.05). In conclusion, expressions of maspin and syndecan-1 are not strongly representative of differences in behavior between OKC, AB, and DC. However, the expression of Ki-67 indicates comparable proliferative activities of OKC and AB, which are higher than that of DC. Further investigation on the biologic behavior of OKC is still recommended to arrive at more specific conclusions regarding its classification.


  • Open Access

    Rare Benign cystic teratoma in the parotid gland

    by Mahmoud M. Gharaibeh, Ahmed Al Wadiya, United Kingdom Royal Derby Hospital, Ahmad Gharaibeh, Hdua Hammad

    Introduction. A teratoma is a tumor developed of several different types of tissue, like hair, muscle, teeth or bone. Aim. Mature benign cystic teratomas are very rare in the salivary glands and just few cases were reported. Description of the case. A 13 years old female was presented to our dental clinic of Princes Basma Hospital in Irbid in north of Jordan, with a painless, insidious progressive swelling in left parotid region without any significant family and personal history. Parents were cancer phobic and nervous from the condition of their daughter, they were very confused. There was no pain or any history of trauma. It was present just inferior to left ear cartilage. The mass was of size 3x3cm, non-tender, fixed, soft to firm in consistency, having smooth surface. Conclusion. Teratoma in parotid region is an extremely rare entity. Lack of any pathognomonic feature, it is hard to diagnose preoperatively. Lumpectomy is advisable to remove the mass because the risk of damaging facial nerve in young patients and recurrence is rare. A definitive diagnosis is achieved after the histopathological study. Teratoma should be kept in account while evaluating a case of a soft tissue mass of parotid gland as a differential diagnosis.


  • Odontogenic myxoma with diffuse calcifications: a case report and review of a rare histologic feature

    by Huda M. Hammad, Yousef M. Hasen, Abd-Albaset M. Odat, Abeer M. Mikdadi, Rima A. Safadi


  • Histological evaluation of rat tissue response to GMTA, Retroplast, and Geristore retrograde filling materials

    by Huda M. Hammad, Mohammed A. Hamadah, Wael M. Al-Omari

    The aim of the study was to compare the short-term biocompatibility of grey mineral trioxide aggregate (GMTA), Retroplast and Geristore. Silicon tubes filled with the materials and empty control tubes were implanted in the dorsal connective tissue of 30 Wistar albino rats. The tubes and surrounding tissues were excised and prepared for histological examination at 1 week, 1 month and 2 months after implantation. Inflammatory cell counts and the presence or absence of necrosis adjacent to the materials and control tubes were recorded. Data were statistically analysed using one-way anova and Tukey's multiple comparisons tests. The empty control tubes were well tolerated. All tested materials showed a more severe initial reaction than the control group. With time, the reaction became chronic, with variable increase in the numbers of inflammatory cells. Retroplast recorded the most statistically significant increase in the sum of inflammatory cells. Although the increase in the sum of inflammatory cells was statistically significant for Geristore but not for GMTA, the inflammatory cell counts for both were comparable. It was concluded that the three materials continued to irritate tissues throughout the evaluation period. Retroplast was the least biocompatible of the three tested materials at 2 months, followed by Geristore then GMTA.


  • Effects of topically applied agents on intra-oral wound healing in a rat model: a clinical and histomorphometric study*

    by Hm Hammad, Mm Hammad, In Abdelhadi, M S Khalifeh

    Topically applied chlorhexidine and hyaluronan have many studies supporting their use to enhance oral wound healing. Allantoin is widely used topically to promote epithelial proliferation and wound healing, with very little scientific evidence to support such uses. This study investigated and compared the influence of these agents on the healing of intra-oral excisional wounds with large epithelial and connective tissue defects. Excisional wounds, 3 mm in diameter, were made at the centre of the palate of 125 Wistar male albino rats. Five animals constituted the baseline group at time 0. The remaining animals were divided into four experimental and one control groups, in which chlorhexidine digluconate gel 0.2% (Perio.Kin®), hyaluronan gel (Gengigel®), allantoin 0.5% in vehicle gel, vehicle gel alone and nothing were applied daily to the wounds. The wound areas were measured photographically and the epithelialization rates were determined histologically at 0, 3, 7, 14 and 21 days post-surgery. The mean wound area and mean distance between the epithelial margins decreased significantly with time in all experimental and control groups (P < 0.05). A significant rate of wound area reduction was observed following the use of Perio.Kin® and Gengigel® at 7 and 14 days. Perio.Kin® showed a significant rate of wound epithelialization at 7 days. Allantoin did not positively or negatively affect wound healing. None of the tested agents had a negative effect on the rate of wound healing when applied on an excisional wound with epithelial and connective tissue defect. Positive results were achieved with Perio.Kin® and Gengigel®.


  • Open Access

    Orofacial findings in chronic granulomatous disease: report of twelve patients and review of the literature

    by Najla S Dar-Odeh, Wail A Hayajneh, Osama A Abu-Hammad, Huda M Hammad, Adel M Al-Wahadneh, Najwa K Bulos, Azmi M Mahafzah, Maha S Shomaf, Mohammed A El-Maaytah, Faris G Bakri

    Chronic granulomatous disease is an extremely rare primary immunodeficiency syndrome that can be associated with various oral complications. This can affect high number of patients. However, data on oral complications is sparse. Here we will review the literature and describe the orofacial findings in 12 patients.